Tim Mccarthy Email & Phone Number

Bridgewater, New Jersey, Us

Theranica brings remote electrical neuro-modulation therapy (REN) to a new and innovative level. We develop advanced drug-free, non-invasive solutions for migraine sufferers. Our wearable devices are controlled by smartphone applications in order to easily adapt treatments to today’s modern lifestyle

Dartmouth, Ns, Ca

Innovator of pain management and mobility solutions for active people seeking noninvasive alternatives

Middletown, Pa, Us

HydroWorx allows people to achieve their potential by accelerating healing through the advanced and unique integration of technology and water. The leader in hydro-therapy technology solutions from aquatic design and construction services thru programing implementation, and key supplier to the sports performance, healthcare and senior living wellness markets.► Recruited as chief executive to leverage sports performance success into additional channels in order to grow a static business.► Developed and executed the commercial strategies (product and customer) allowing broader access into the exponentially larger healthcare, senior living, wellness and fitness channels.► Grew revenues by 35% and EBITDA by 85% within first two years, setting record highs for several key performance indicators in the thirty year history of the Company.► Exceeded annual EBITDA budget target for three consecutive years while improving gross margins by 12% and building a $70 Million active sales pipeline to drive future growth.

Watertown, Ma, Us

Global research robotics company providing neuro rehabilitation technology solutions from hospital to home.► Recruited to set long-term commercial goals, finalize product developmental and go to market strategies, and lead initial go-to-market company launch plans. Pivoting from an entirely research based organization to one with commercial scale capabilities. ► Raised required in capital to complete key product development projects and build the commercial infrastructure required to support initial demand generating activities.► Defined capital equipment sales process and built a $30M sales pipeline designed to generate a $7M annual sales run rate by 2018 with single product. Active sales opportunities mapped to web based CRM (SalesForce) complete with process metrics, analytics and probability forecasting capability. ► Built organization’s Customer Service & Support, Clinical Education, Sales Operations & Logistics, Up and Downstream Marketing, Lead Generation & Pipeline Dashboards, all with key performance metrics.

MCS is a leader in innovative, non-invasive solutions for the prevention of post surgical venous thromboembolism (VTE). ► Recruited as chief executive to lead a commercial stabilization and turnaround effort to prepare the Company for an M&A transaction in 2016 with Zimmer Biomet. Raised required in capital to fund turnaround and M&A effort.► Reversed revenue decline and achieved annual sales goal of $9M while growing strategic product sales by 10%. ► Transitioned 50% of U.S. FTE’s from demand generation to demand support; recruited talent to build a profitable and scalable commercial sales model. ► Built US based Customer Care Center to support demand generation through world class customer service, clinical education, patient engagement, sales analytics, product logistics and third party billing operations. ► Developed profitable reimbursement pathway via the Center for Medicare and Medicaid Services (CMS) bundled payment care initiative (BPCI) for product treatment to be covered by Medicare ► Successfully negotiated the Company’s first “standard of care” agreements with high volume bundled payment providers, including NYU Langone and Barnes Jewish Hospital. ► Reduced operating loss by ~50% and exceeded cash-on-hand budget by $3M while achieving top line goals. This extended the runway and reduced the need for additional dilutive capital during an M&A year.

Technology leader delivering the only lower-limb prosthesis with powered propulsion for enhanced and normalized mobility. ► Recruited as chief executive to lead all aspects of corporate strategy and establish a long-term market foothold; the company valuation increased 7x to over $100M during tenure.► Generated $35M+ in first generation product sales from successful launch into the US, UK and Canada; created partnership with the US Department of Defense and the Veterans Administration.► Raised over $40M in venture capital to fund final product development and commercial scale. ► Established research collaboration and commercial clinical partnership with the US Department of Defense and US Veterans Administration.► Executed comprehensive reimbursement strategy resulting in a Center for Medicare and Medicaid (CMS) approved and product specific HCPCS reimbursement code, broadly expanding payer access and increasing average reimbursement.► Guided all product development phases, published three peer-reviewed clinical studies, and achieved all compliance requirements to meet FDA and CE regulatory guidelines for market launch.

Reykjavik, Iceland, Is

► Promoted by CEO as commercial executive and leader of a sales and marketing restructuring effort, resulting in above budget attainment each year and 4.5x revenue growth. This was done through aggressive market share conversion, launching innovative new products, developing market-ready services (B2C and reimbursement), and strategic acquisitions. ► Key leader in Össur‘s transition from a customer service-focused business to a direct global sales strategy, growing revenue from $25M to $350M.► Averaged 70% gross margins across blended product lines delivering between 25-30% EBITDA each year for six consecutive years. Managed a $30M annual S&M budget to target. ► The company valuation increased 10x ($750M market cap) during tenure.

Mba

Bachelor Of Science, International Business